HOME > VC DEALS > Serif Biomedicines
Deal IconDeal

Serif Biomedicines

Serif Biomedicines raises $50M

Serif Biomedicines, a Cambridge, MA-based biotech developing modified DNA, raised $50 million in an initial commitment financing led by Flagship Pioneering.

More on VC News Daily →


ADVERTISEMENT carta_vcd_page_OCFO

Similar Health deals

The VC Industry's trusted resource

Stay informed on industry shifts, deal trends, and career opportunities in venture capital.

Jobs